Seer Showcases Deep Proteomics Capabilities, Announces Co-Marketing Deal with Thermo Fisher Scientific
At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and strengthen other forms of omics data. Through various sessions at the meeting, the company highlighted applications of...
Breakthrough research reveals how to target malignant DNA in aggressive cancers
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments. In three groundbreaking papers published...
MD Anderson launches new institute for advancing cell therapy
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and research expertise to lead...
Cancer-Fighting Zeal Regained by Tired T Cells Deprived of Lactic Acid
As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Newly reported research by scientists at the University of Pittsburgh and UPMC Hillman Cancer Center suggests that...
Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration
As it builds a pipeline of artificial intelligence (AI)-designed treatments, Absci has reached out to its preferred supplier of DNA for its latest collaboration—one of three partnerships that the AI drug developer has either...
Inscripta Reports Successful Scaleup of an Anti-Aging Skincare Ingredient
Officials at Inscripta say they successfully completed scale-up runs and are moving into commercial manufacturing of an anti-aging skincare ingredient.
Commercial biomanufacturing addresses serious challenges in sourcing plant-based ingredients, according to a company spokesperson, including...
PacBio Launches Vega Benchtop, Hopes People Get “Hooked on HiFi”
If ASHG attendees can count on one thing lately, it’s PacBio creating a buzz (and throwing a great party). The company has developed a reputation for launching its products with flair, typically accompanied by...
Study links nasal autoantibodies to COVID-19 severity prediction
A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially greater risk of...
Solascure and U.S. Army Institute of Surgical Research collaborate for combat wound care
SOLASCURE Ltd ("SolasCure"), a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army Institute of Surgical Research ("USAISR"), today announced a research collaboration to evaluate SolasCure's investigational product,...
Advancing vaccine development through green biotechnology
The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year. In Romania, the prevalence of both diseases is notably high, creating an urgent...
